Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open label, randomised controlled trial
February 2010
Commentary by Professor Paul Harnett and Dr Alexander Menzies
Clinical Update - Ovarian cancer
|
Putting research into context, Clinical Update - Ovarian cancer is produced by the National Breast and Ovarian Cancer Centre (NBOCC) as a free service for health professionals, delivering timely expert comment on relevant journal articles direct to your email inbox. A brief abstract summarises key findings from a recent journal article, while commentary from an expert reviewer places the study outcomes into context for the Australian healthcare system. Editor: Dr Anne Nelson, Evidence Review and Research Leader, NBOCC Editorial Committee: Prof Michael Friedlander – Medical Oncologist, Prof Neville Hacker – Gynaecological Oncologist, Ms Kim Hobbs - Social Worker, Dr Gillian Mitchell – Medical Oncologist, Dr Deborah Neesham – Gynaecological Oncologist, Ms Georgie Richter – Gynaecological Nurse. |
|
|
|
|
|
|
Quick feedback
© Copyright National and Ovarian Cancer Centre 2009
Patron: Her Excellency Ms Quentin Bryce AC, Governor-General of the Commonwealth of Australia